University of Cambridge > Talks.cam > Computational and Systems Biology > Understanding tumour heterogeneity in glioblastoma

Understanding tumour heterogeneity in glioblastoma

Download to your calendar using vCal

If you have a question about this talk, please contact Emily Boyd .

We have undertaken an integrated genomic analysis of the evolution of Glioblastoma (GB) in individual patients across multiple spatial scales. Our data reveal early clonal diversification generating a genetically complex and highly evolved disease environment at clinical presentation. We propose that these fundamental patient-specific tumor evolutionary dynamics underlie clinical phenotypic heterogeneity and may have implications for the emergence of resistant disease. Using a Fluorescence-Guided Multiple Sampling technique we obtained samples from the tumor mass, the sub-ependymal zone and the non-fluorescent tumor margin. These data allow us to study intra-tumour heterogeneity, which is likely to be the key to understanding treatment failure. I will describe our approach, and discuss a statistical problem that arises in the analysis of dependent samples.

This talk is part of the Computational and Systems Biology series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

Β© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity